| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sujin Jeong, Yoseob Kim, Sanggil Choe, Hyunwook Kang, Hyung Min Kim, Jong Seong Kan. A fatal case of desvenlafaxine and paroxetine poisoning. Journal of pharmaceutical and biomedical analysis. vol 245. 2024-04-23. PMID:38652939. |
despite their relatively safe profiles, several serious side effects, including serotonin syndrome, bleeding, mania, and high blood pressure, are observed. |
2024-04-23 |
2024-04-26 |
Not clear |
| Phillip Hazel. Antidepressants in adolescence. Australian prescriber. vol 45. issue 2. 2022-05-20. PMID:35592362. |
these include suicide-related behaviours, switching to mania, and serotonin syndrome. |
2022-05-20 |
2023-08-13 |
Not clear |
| Megan F Joseph, Eric A Youngstrom, Jair C Soare. Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. Future neurology. vol 4. issue 1. 2021-10-20. PMID:19884978. |
antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. |
2021-10-20 |
2023-08-12 |
Not clear |
| Christoph U Correll, Samuele Cortese, Giovanni Croatto, Francesco Monaco, Damir Krinitski, Gonzalo Arrondo, Edoardo G Ostinelli, Caroline Zangani, Michele Fornaro, Andrés Estradé, Paolo Fusar-Poli, Andre F Carvalho, Marco Solm. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 20. issue 2. 2021-05-27. PMID:34002501. |
based on the meta-analytic evidence, the most convincing efficacy profile emerged for amphetamines, methylphenidate and, to a smaller extent, behavioral therapy in attention-deficit/hyperactivity disorder; aripiprazole, risperidone and several psychosocial interventions in autism; risperidone and behavioral interventions in disruptive behavior disorders; several antipsychotics in schizophrenia spectrum disorders; fluoxetine, the combination of fluoxetine and cognitive behavioral therapy (cbt), and interpersonal therapy in depression; aripiprazole in mania; fluoxetine and group cbt in anxiety disorders; fluoxetine/selective serotonin reuptake inhibitors, cbt, and behavioral therapy with exposure and response prevention in obsessive-compulsive disorder; cbt in post-traumatic stress disorder; imipramine and alarm behavioral intervention in enuresis; behavioral therapy in encopresis; and family therapy in anorexia nervosa. |
2021-05-27 |
2023-08-13 |
Not clear |
| Rosaria Nardello, Fulvio Guccione, Claudia Gliubizzi, Antonio Marino, Mariarita Capizzi, Salvatore Mangan. Resolution of enuresis with aripiprazole in children with psychiatric disorders: two case reports. Journal of medical case reports. vol 15. issue 1. 2021-05-14. PMID:33883037. |
as partial agonist of the dopamine (d2) and serotonin (5-ht1a) receptors, it appears to be effective in reducing mania in patients with bipolar disorder, tics in tourette syndrome, aggression in schizophrenia and autism spectrum disorder. |
2021-05-14 |
2023-08-13 |
Not clear |
| Jerrold C. Winter, David J. Fiorella, Scott E. Helsley, Richard A. Rabi. Partial generalization of (-)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis. The international journal of neuropsychopharmacology. vol 2. issue 3. 2019-11-20. PMID:11281985. |
the present data are compatible with a 5-ht(2)-mediated effect of fluvoxamine which may play a role in ssri-induced mania and psychosis. |
2019-11-20 |
2023-08-12 |
rat |
| Louise Sharkey, Ann O'Donova. Paroxetine induced mania in pre-adolescence. Irish journal of psychological medicine. vol 21. issue 1. 2019-11-20. PMID:30308728. |
selective serotonin reuptake inhibitor induced mania has been described in adults, and more recently in adolescents. |
2019-11-20 |
2023-08-13 |
Not clear |
| Nousha Hefzi, Jeremy Grekin, Aisha Ahme. Mania induced by tramadol-venlafaxine combination. Journal of opioid management. vol 15. issue 4. 2019-10-28. PMID:31637686. |
tramadol-induced mania has been described with selective serotonin reuptake inhibitors but not snris. |
2019-10-28 |
2023-08-13 |
Not clear |
| Hesitha Abeysundera, Ramandeep Gil. Possible SAMe-induced mania. BMJ case reports. vol 2018. 2018-10-31. PMID:29950497. |
this paper describes a patient who presented with mania with psychotic features in the context of concomitant use of s-adenosyl-l-methionine (same) and selective serotonin reuptake inhibitor (ssri). |
2018-10-31 |
2023-08-13 |
Not clear |
| Sarah Delcourte, Erika Abrial, Adeline Etiévant, Renaud Rovera, Jørn Arnt, Michael Didriksen, Nasser Haddjer. Asenapine modulates mood-related behaviors and 5-HT CNS neuroscience & therapeutics. vol 23. issue 6. 2018-03-12. PMID:28417559. |
the objective of this study was to investigate its antidepressant-like and antimanic-like properties on relevant animal models of depression and mania and to assess the acute and chronic effect of asenapine on dorsal raphe nucleus (drn) 5-ht cell firing activity. |
2018-03-12 |
2023-08-13 |
Not clear |
| K Fukud. Integrated theory to unify status among schizophrenia and manic depressive illness. Medical hypotheses. vol 85. issue 4. 2016-07-12. PMID:26141636. |
although decreased serotonin activity has been reported in both depression and mania, it is important to investigate the interaction between serotonin and other neurotransmitter systems. |
2016-07-12 |
2023-08-13 |
Not clear |
| Mark A Frye, Susan L McElroy, Miguel L Prieto, Kelly L Harper, Denise L Walker, Simon Kung, Mohit Chauhan, Scott Crow, Bruce Sutor, Christine W Galardy, Marin Veldic, Brian A Palmer, Jennifer R Geske, Manuel Fuentes, Alfredo B Cuellar-Barboza, Lisa R Seymour, Nicole Mori, Joanna M Biernack. Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania. The Journal of clinical psychiatry. vol 76. issue 2. 2015-04-27. PMID:25611077. |
clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania. |
2015-04-27 |
2023-08-13 |
Not clear |
| Alexis R Howerton, Alison V Roland, Tracy L Bal. Dorsal raphe neuroinflammation promotes dramatic behavioral stress dysregulation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 34. issue 21. 2014-07-11. PMID:24849347. |
serotonin cell bodies originating within the dorsal raphe (dr) play a major role in the regulation of behavioral features characteristic of mania. |
2014-07-11 |
2023-08-13 |
mouse |
| Cristina Stasi, Massimo Rosselli, Anna Linda Zignego, Giacomo Laffi, Stefano Milan. Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions. Hepatology research : the official journal of the Japan Society of Hepatology. vol 44. issue 1. 2014-01-06. PMID:23607322. |
serotonin reuptake inhibitors significantly improve mood disorders, but the use of these drugs requires caution because some studies reported the emergence of mania in patients treated for depression during antiviral therapy. |
2014-01-06 |
2023-08-12 |
Not clear |
| Joseph F Goldber. A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression. Journal of affective disorders. vol 144. issue 1-2. 2013-09-24. PMID:22858262. |
we hypothesized that nefazodone added to a standard mood stabilizer would show significant antidepressant efficacy with minimal agitation or induction of mania, by virtue of its selective 5-ht(2a) blockade. |
2013-09-24 |
2023-08-12 |
Not clear |
| Susanne Nikolaus, Hubertus Hautzel, Alexander Heinzel, Hans-Wilhelm Mülle. Key players in major and bipolar depression--a retrospective analysis of in vivo imaging studies. Behavioural brain research. vol 232. issue 2. 2012-10-22. PMID:22483788. |
moreover, in depression, limbic 5-ht(1a) receptors were elevated, whereas in mania a decrease of both cortical and limbic 5-ht(2a) receptor binding was observed. |
2012-10-22 |
2023-08-12 |
Not clear |
| Joanna M Biernacka, Susan L McElroy, Scott Crow, Alexis Sharp, Joachim Benitez, Marin Veldic, Simon Kung, Julie M Cunningham, Robert M Post, David Mrazek, Mark A Fry. Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. Journal of affective disorders. vol 136. issue 1-2. 2012-04-26. PMID:21680025. |
pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5httlpr) association. |
2012-04-26 |
2023-08-12 |
Not clear |
| V Sathyanarayana, S Khanna, S M Channabasavann. Clomipramine induced mania. Indian journal of psychiatry. vol 33. issue 3. 2011-11-10. PMID:21927502. |
the link between serotonin and mania is speculated upon. |
2011-11-10 |
2023-08-12 |
Not clear |
| Michelle Goldsmith, Manpreet Singh, Kiki Chan. Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Paediatric drugs. vol 13. issue 4. 2011-10-11. PMID:21692547. |
for children with depression and/or anxiety, the risk of antidepressant-induced mania (aim) was generally low (<2%), but the risk of general 'activation' secondary to a selective serotonin reuptake inhibitor (ssri) may be greater (2-10%). |
2011-10-11 |
2023-08-12 |
Not clear |
| L Lykouras, M Markianos, Y Hatzimanoli. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity. Neuropsychobiology. vol 63. issue 2. 2011-05-25. PMID:21178381. |
although the role of serotonin has received a great deal of attention using neuroendocrine challenge paradigms, little effort has been made to explore the role of serotonin in mania. |
2011-05-25 |
2023-08-12 |
human |